User login
Michael L. Krychman, MD
Executive Director, Southern California Center for Sexual Health and Survivorship Medicine
Newport Beach, California
Alyssa Dweck, MD
CareMount Medical, PC, Mt. Kisco, New York
Assistant Clinical Professor, Department of Obstetrics, Gynecology, and Reproductive Science
Mount Sinai School of Medicine, New York, New York
Consultant, Massachusetts General Hospital, Vincents Memorial Ob/Gyn Service
Boston, Massachusetts
Sheryl Kingsberg, PhD
Chief, Division of Behavioral Medicine, Department of Obstetrics & Gynecology
University Hospitals, Cleveland Medical Center
Professor, Reproductive Biology and Psychiatry
Case Western Reserve University School of Medicine
Cleveland, Ohio
Lisa Larkin, MD
President, Lisa Larkin, MD, & Associates
Cincinnati, Ohio
Dr. Krychman reports receiving research support from New England Research Institutes (NERI) and being a consultant for Palatin, Shionogi, Inc, Sylk USA, TherapeuticsMD, and Valeant Pharmaceuticals; a speaker for Shionogi and Valeant; and an advisor for Uniderm.
Dr. Dweck reports being a consultant to Uniderm and a speaker for Bayer Pharmaceuticals.
Dr. Kingsberg reports receiving grant or research support from Palatin; being a consultant to Acerus, AMAG, Emotional Brain, EndoCeutics, Materna, NovoNordisk, Nuelle, Palatin, Pfizer, Scientific Strategic Solutions, Shionogi, TherapeticsMD, and Valeant Pharmaceuticals; and being a speaker for Valeant.
Dr. Larkin reports being a consultant and speaker for Valeant Pharmaceuticals.
OBG Management and the roundtable faculty do not endorse any specific product mentioned over another in this roundtable discussion.
Michael L. Krychman, MD
Executive Director, Southern California Center for Sexual Health and Survivorship Medicine
Newport Beach, California
Alyssa Dweck, MD
CareMount Medical, PC, Mt. Kisco, New York
Assistant Clinical Professor, Department of Obstetrics, Gynecology, and Reproductive Science
Mount Sinai School of Medicine, New York, New York
Consultant, Massachusetts General Hospital, Vincents Memorial Ob/Gyn Service
Boston, Massachusetts
Sheryl Kingsberg, PhD
Chief, Division of Behavioral Medicine, Department of Obstetrics & Gynecology
University Hospitals, Cleveland Medical Center
Professor, Reproductive Biology and Psychiatry
Case Western Reserve University School of Medicine
Cleveland, Ohio
Lisa Larkin, MD
President, Lisa Larkin, MD, & Associates
Cincinnati, Ohio
Dr. Krychman reports receiving research support from New England Research Institutes (NERI) and being a consultant for Palatin, Shionogi, Inc, Sylk USA, TherapeuticsMD, and Valeant Pharmaceuticals; a speaker for Shionogi and Valeant; and an advisor for Uniderm.
Dr. Dweck reports being a consultant to Uniderm and a speaker for Bayer Pharmaceuticals.
Dr. Kingsberg reports receiving grant or research support from Palatin; being a consultant to Acerus, AMAG, Emotional Brain, EndoCeutics, Materna, NovoNordisk, Nuelle, Palatin, Pfizer, Scientific Strategic Solutions, Shionogi, TherapeticsMD, and Valeant Pharmaceuticals; and being a speaker for Valeant.
Dr. Larkin reports being a consultant and speaker for Valeant Pharmaceuticals.
OBG Management and the roundtable faculty do not endorse any specific product mentioned over another in this roundtable discussion.
Michael L. Krychman, MD
Executive Director, Southern California Center for Sexual Health and Survivorship Medicine
Newport Beach, California
Alyssa Dweck, MD
CareMount Medical, PC, Mt. Kisco, New York
Assistant Clinical Professor, Department of Obstetrics, Gynecology, and Reproductive Science
Mount Sinai School of Medicine, New York, New York
Consultant, Massachusetts General Hospital, Vincents Memorial Ob/Gyn Service
Boston, Massachusetts
Sheryl Kingsberg, PhD
Chief, Division of Behavioral Medicine, Department of Obstetrics & Gynecology
University Hospitals, Cleveland Medical Center
Professor, Reproductive Biology and Psychiatry
Case Western Reserve University School of Medicine
Cleveland, Ohio
Lisa Larkin, MD
President, Lisa Larkin, MD, & Associates
Cincinnati, Ohio
Dr. Krychman reports receiving research support from New England Research Institutes (NERI) and being a consultant for Palatin, Shionogi, Inc, Sylk USA, TherapeuticsMD, and Valeant Pharmaceuticals; a speaker for Shionogi and Valeant; and an advisor for Uniderm.
Dr. Dweck reports being a consultant to Uniderm and a speaker for Bayer Pharmaceuticals.
Dr. Kingsberg reports receiving grant or research support from Palatin; being a consultant to Acerus, AMAG, Emotional Brain, EndoCeutics, Materna, NovoNordisk, Nuelle, Palatin, Pfizer, Scientific Strategic Solutions, Shionogi, TherapeticsMD, and Valeant Pharmaceuticals; and being a speaker for Valeant.
Dr. Larkin reports being a consultant and speaker for Valeant Pharmaceuticals.
OBG Management and the roundtable faculty do not endorse any specific product mentioned over another in this roundtable discussion.
